erythrosine has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantolino, SJ | 1 |
| O'Grady, GE | 1 |
| Herrera, JA | 1 |
| Israel, C | 1 |
| Justice, J | 1 |
| Flynn, JT | 1 |
1 other study available for erythrosine and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia.
Topics: Acute Disease; Female; Fluoresceins; Fundus Oculi; Humans; Infant; Infant, Newborn; Male; Ophthalmos | 1971 |